Details for Patent: 11,753,632
✉ Email this page to a colleague
Which drugs does patent 11,753,632 protect, and when does it expire?
Patent 11,753,632 protects OPFOLDA and is included in one NDA.
This patent has sixty patent family members in thirty-six countries.
Drugs Protected by US Patent 11,753,632
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therap Us | OPFOLDA | miglustat | CAPSULE;ORAL | 215211-001 | Sep 28, 2023 | RX | Yes | Yes | 11,753,632 | ⤷ Subscribe | THE TREATMENT OF POMPE PATIENTS | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,753,632
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3201320 | ⤷ Subscribe | 301267 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3201320 | ⤷ Subscribe | LUC00336 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 3201320 | ⤷ Subscribe | CA 2024 00012 | Denmark | ⤷ Subscribe |
| European Patent Office | 3201320 | ⤷ Subscribe | PA2024509 | Lithuania | ⤷ Subscribe |
| European Patent Office | 3201320 | ⤷ Subscribe | 2024C/513 | Belgium | ⤷ Subscribe |
| European Patent Office | 3201320 | ⤷ Subscribe | 122024000016 | Germany | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
